Home / Mass Tort / Active Dockets / Depo-Provera

Mass Tort Docket · Actively Screening

Depo-Provera and Meningioma Risk

Women who used Depo-Provera contraceptive injections long-term (one year or more) and have been diagnosed with meningioma (a brain tumor) may have a claim. A 2024 BMJ study linked long-term medroxyprogesterone use to increased meningioma risk. Jim Glaser Law screens Massachusetts claims at no cost.

Free first call (617) JIM-WINS

What this docket is about

Depo-Provera is the brand name for the medroxyprogesterone acetate injectable contraceptive, marketed by Pfizer (and originally Upjohn). A 2024 BMJ study found that women who used the injection for one year or more had a meaningfully elevated risk of intracranial meningioma. Multidistrict litigation has formed. Massachusetts plaintiffs are eligible to participate. Documentation of injection dates, prescribing pharmacy, and meningioma diagnosis are the central proofs.

Who may qualify

The firm screens for the following criteria. Meeting all of them is not a guarantee of acceptance; the actual evaluation happens in conversation with the firm.

  • Used Depo-Provera (medroxyprogesterone acetate injection) for one year or more, in any time period
  • Diagnosed with meningioma (a brain tumor) at any point after use began
  • Diagnosis can be confirmed with medical records (MRI report, neurology / neurosurgery records)
  • Lived in Massachusetts at the time of use or diagnosis

Free Massachusetts Screening

Find out if you may qualify for the Depo-Provera docket.

Five short questions. No fee. No obligation. Submission goes directly to Jim Glaser Law's intake team for review. The line is answered 24/7 if you would rather telephone first: (617) JIM-WINS.

  1. 01
    Did you use Depo-Provera (the contraceptive injection)?
  2. 02
    Roughly how long did you use it?
  3. 03
    Have you been diagnosed with a meningioma (brain tumor)?
  4. 04
    Approximately when was the meningioma diagnosed?
  5. 05
    Were you a Massachusetts resident at the time of use or diagnosis?

How should the firm reach you?

Provide a phone number or email. The firm reaches out within one business day. Submitting this screening does not, by itself, create an attorney-client relationship.

This screening collects information for the purpose of evaluating eligibility for the Depo-Provera mass-tort docket. Submission does not, by itself, create an attorney-client relationship. Past results do not guarantee future outcomes. Attorney advertising under Mass. R. Prof. C. 7.1 to 7.5. Responsible attorney: Jim Glaser, admitted in MA only, of counsel to Keches Law. Principal office: 77 Pond St., Sharon, MA. Most cases referred to other jurisdictionally licensed lawyers for principal liability.

What happens after you submit

The screening lands directly in Jim Glaser Law's intake queue with the docket name and your answers. The firm reaches out within one business day to confirm fit and explain next steps. Cases that fit the docket are filed by the firm or coordinated with national lead counsel as appropriate. Cases that do not fit are referred without fee to other Massachusetts counsel where appropriate.

Mass tort representation is typically on contingency, meaning no attorney's fee unless and until the matter resolves with a recovery to the client; case-related costs and expenses are addressed in the written fee agreement.

This page constitutes legal information, not legal advice. Past results do not guarantee future outcomes. Attorney advertising under Mass. R. Prof. C. 7.1 to 7.5. Responsible attorney: Jim Glaser, admitted in MA only, of counsel to Keches Law. Principal office: 77 Pond St., Sharon, MA. Most cases referred to other jurisdictionally licensed lawyers for principal liability.